Neuro Kinetics, Inc

Form 483 issued July 2, 2019 · Pittsburgh, Pennsylvania

Inspection
Jun 17 – Jul 2, 2019
Investigator
Dennis R. Hock
Observations
4
Pages
4
FEI number
2519945

In short: On July 2, 2019, FDA issued a Form 483 with 4 observations to Neuro Kinetics, Inc in Pittsburgh, Pennsylvania (FEI 2519945) after an inspection that ran Jun 17 – Jul 2, 2019. The investigator was Dennis R. Hock. Most observations concern design controls and cAPA; the most-cited regulation is 21 CFR 820.30 (design controls).

At a glance

Design controls and capa account for 3 of 4 observations.

Design controls2
CAPA1
Production & process controls1

Most cited: 21 CFR 820.30(g) (2×)

What FDA observed

Preview: the opening words of each observation
  1. 01

    Design validation did not ensure the device conforms to defined user…

  2. 02

    Acceptance criteria were not established prior to the…

  3. 03

    Procedures have not been adequately established to control product that does not…

  4. 04

    Procedures for acceptance of incoming product have…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Neuro Kinetics, Inc?

FDA listed 4 observations on this Form 483, mostly about design controls, cAPA and production & process controls. The most-cited regulation is 21 CFR 820.30 (design controls). The opening words of each observation are shown on this page.

Who inspected Neuro Kinetics, Inc?

Dennis R. Hock is named on this Form 483, for the inspection of Jun 17 – Jul 2, 2019. Each investigator has a profile showing what they cite most.

When was Neuro Kinetics, Inc inspected by FDA?

The inspection ran Jun 17 – Jul 2, 2019, and the Form 483 is dated July 2, 2019.

How do I get the full Form 483 for Neuro Kinetics, Inc?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free